Medicine and Dentistry
Acute Myeloid Leukemia
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
100%
Arsphenamine
66%
Cytarabine
33%
Engraftment
33%
Platelet
33%
Drug Megadose
33%
Bone Marrow Transplantation
33%
Apheresis
33%
Granulocyte Colony Stimulating Factor
33%
Overall Survival
33%
Disease Free Survival
33%
Granulocyte
33%
Graft Versus Host Reaction
33%
Methotrexate
33%
Filgrastim
33%
Keyphrases
Graft-versus-host Disease (GvHD)
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
100%
Lymphoblastic Leukemia
100%
Bone Marrow Transplantation
20%
Twice Daily
20%
Platelets
20%
Engraftment
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Leukemia Patients
20%
Patient Dose
20%
CD34+ Cells
20%
Overall Survival
20%
Conditioning Regimen
20%
HLA-identical Sibling
20%
Disease-free Survival
20%
Granulocytes
20%
Transplant-related Mortality
20%
Graft-versus-host Disease Prophylaxis
20%
Apheresis Procedures
20%
In(III)
20%
High-dose Ara-C
20%
Neupogen
20%
Immunology and Microbiology
Allogeneic Peripheral Blood Stem Cell Transplantation
100%
Graft-Versus-Host Disease
33%
Engraftment
33%
Platelet
33%
Granulocyte
33%
Bone Marrow Transplantation
33%
Drug Megadose
33%
Methotrexate
33%
CD34
33%
Overall Survival
33%
Disease Free Survival
33%
Granulocyte Colony-Stimulating Factor
33%
Filgrastim
33%
Apheresis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Arsphenamine
66%
Graft Versus Host Reaction
33%
Methotrexate
33%
Granulocyte Colony Stimulating Factor
33%
Overall Survival
33%
Disease Free Survival
33%
Cytarabine
33%
Filgrastim
33%